Close this search box.

We are creating some awesome events for you. Kindly bear with us.

India Ministry of Science and Tech initiatives against COVID-19

The Indian government’s Ministry of Science and Technology has unleashed a barrage of initiatives in the fight against COVID-19.

Some key efforts include production therapeutic antibodies against COVID-19 as well as exploring novel blood plasma therapy.

The Department of Science & Technology has also funded a startup to develops kits for testing asymptomatic COVID-19 infections. It has also geared up for vaccine production.

An Institution of National Importance under the Department of Science and Technology has received the official nod from the Indian Council for Medical Research (ICMR) to explore innovative treatment to patients suffering from COVID-19 disease.

Technically called “convalescent-plasma therapy”, the institute is concentrating on finding ways to use immunity gained by a recovered patient to treat a sick person.

When a pathogen, (like the novel coronavirus) infects a person, the immune system produces antibodies that identify and mark the invading virus. White blood cells are deployed by the body against the intruding virus.

The therapy seeks to harvest these antibodies from a recovered COVD-19 patient and release them into someone infected. The idea is that the new patients the immune system will get a boost from the introduced antibodies and fight the virus.

In principle, plasma therapy is feasible. However, obtaining significant amounts of plasma from survivors is difficult. This is more when co-morbid conditions like hypertension, diabetes, make harvesting ineffective.

Initially, there will be a small trial as an experimental therapy for severely affected patients only who have provided informed consent. This will be conducted as a clinical trial.

Therapeutic antibodies can be also produced in a laboratory by DNA-based recombinant technologies. Efforts are in full swing globally to produce therapeutic antibodies against SARS-CoV-2.

One such effort is being done at the University of Delhi South Campus-Centre for Innovation in Infectious Disease Research, Education and Training (UDSC-CIIDRET) with the support of the Department of Biotechnology in the Ministry of Science and Technology, Government of India.

The team is isolating genes encoding antibodies, which can neutralise the SARS-CoV-2, using a large antibody library already available in-house as well as a library made from the cells of patients who have recovered from COVID-19 infection.

Another startup, working on new biological technologies, has been funded by the Department of Science and Technology (DST), to undertake the development of Active Virosome (AV)-Vaccine and Immunodiagnostic kits for COVID-19 emergency.

The Council of Scientific & Industrial Research (CSIR) is also intrinsically involved with the COVID-19 efforts.

CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad has been engaged in the fight against COVID-19 on multiple fronts.

Apart from being involved in testing directly, they are also training health professionals and experts to conduct testing.

CSIR labs are also leading the way in genome sequencing of the Corona Virus and CCMB is performing Next Generation Sequencing and analysis to map out the whole genome sequence of the SARS-CoV-2 virus.

Most recently, a science-based website on COVID 19 has been launched. A multi-institutional, multi-lingual science communication initiative, `CovidGyan’ aims to bring scientific and factual aspects of this pandemic outbreak on the public domain.

Apart from being an authentic source of information, the website seeks to create public awareness of the pandemic and efforts being made to combat it.

The Indo-U.S. Science and Technology Forum (IUSSTF), has invited proposals for ‘COVID-19 Indo-U.S. Virtual Networks’.

The proposals would allow Indian and U.S. scientists and engineers currently engaged in COVID-related research to carry out joint research through a virtual mechanism, leveraging existing infrastructure and funding.

Proposals that convincingly demonstrate the benefits and value of the Indo-U.S. partnership to advance research and address critical challenges related to COVID-19 are encouraged.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


CTC Global Singapore, a premier end-to-end IT solutions provider, is a fully owned subsidiary of ITOCHU Techno-Solutions Corporation (CTC) and ITOCHU Corporation.

Since 1972, CTC has established itself as one of the country’s top IT solutions providers. With 50 years of experience, headed by an experienced management team and staffed by over 200 qualified IT professionals, we support organizations with integrated IT solutions expertise in Autonomous IT, Cyber Security, Digital Transformation, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Well-known for our strengths in system integration and consultation, CTC Global proves to be the preferred IT outsourcing destination for organizations all over Singapore today.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.